VISIE (formerly known as Advanced Scanners) recently announced it has raised $8.2 million in an oversubscribed Series A funding round to further its goal of making the unseen seen in surgery. And VISIE is a 3D computer vision and spatial computing company developing deep-tech optical scanners for robotic and navigated orthopedic, neuro, and spine surgery.
The company’s proprietary hardware and software produce snap registration and rich, objective data for image-dependent, imageless robotic, and navigated surgery.
Since being founded in 2017, the company has won numerous awards for its innovative technology, including multiple technology innovation awards and shark tank competitions hosted by the Epilepsy Foundation and the Anterior Hip Foundation.
VISIE has nine U.S. and international patents on its optical scanning technology and continues to secure its IP landscape as it pushes the bounds of what is possible.
Even though VISIE’s first product promises to be in orthopedic surgery, the company is not slowing down on other applications. And in June, it announced a new clinical spine study with a well-known teaching hospital in New England.
VISIE’s optical scanners produce over 1 million data points in a second. And they are designed to simplify surgical workflow and shave significant time off robotic and navigated surgery while simultaneously increasing surgical precision.
KEY QUOTES:
“It was a joy to bring in robotic surgeons and orthopedic industry players to the round. When they saw what the company can do for image registration in robotic and navigated surgery, as well as the promise of pinless robotic surgery, they wanted in.”
— Lon White, medtech industry veteran and VISIE board member
“It’s been gratifying to see long-time and new investors, including industry insiders, come into the round. We are constantly researching and developing ways to improve the surgical experience. We are doing this for patients and surgeons, and to have surgeons’ votes of confidence means the world to us.”
— Doug Fairbanks, VISIE CEO
“It’s a tough fundraising environment. Even the most promising technology companies are struggling, which makes this oversubscribed round special.”
— Rey Madolora, VISIE’s CFO and serial tech entrepreneur, who was added to VISIE’s leadership team during the fundraise to provide expert financial analysis, address complex operational challenges, and drive strategic initiatives
“Orthopedics is exciting for us because of the great numbers of people we can help, and we have not lost sight of our roots in neurosurgery.”
— Aaron Bernstein, PhD, VISIE co-founder and CTO
